Insiders Trades

★ Sign in to follow

KW

Kevin Waters

Chief Financial Officer

US·SEC (Form 4)

PROCEPT BioRobotics Corp

Insider activity · 24 months0 buys4 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 2 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 1 saleApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 1 saleOct 26 · 0 buys · 0 sales

Total declarations

69

Companies

2

▲ Purchases (0 ops.)

—

▼ Sales (31 ops.)

€12.3M

Latest filing published 10 Sept 2026 for PROCEPT BioRobotics Corp, €6,719.

Filing timeline

BuySale

Kevin Waters

Insider track record

Disclosed buys

0

Disclosed sells

31

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Kevin Waters: trading record in brief

Kevin Waters, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in PROCEPT BioRobotics Corp and Accuray Inc. Between 30 September 2015 and 9 September 2026, the trades on record add up to 69 filings.

The open-market record consists of 31 sales worth €12.3M, with no purchase. Besides market trades, the filings include 25 share grants and 13 option exercises. In 2026 alone, the filings show no purchases and 3 sales.

The latest filing, published on 10 September 2026, reports an open-market sale of €6,719 in PROCEPT BioRobotics Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Kevin Waters

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

PROCEPT BioRobotics Corp (US)

Declarations24 total

▼

EVP, CFOExecutives9 Sept 2026PROCEPT BioRobotics Corp

7,815 USD39SEC

373 shares@ US$20.9530.0007% mcap0.3% of flowCommon StockSEC:0001653771-26-000002:0

◆

EVP, CFOExecutives13 Aug 2026PROCEPT BioRobotics Corp

0SEC

29,527 shares0Common StockSEC:0001628280-26-057160:0

▼

EVP, CFOExecutives17 Mar 2026PROCEPT BioRobotics Corp

19,876 USD31SEC

706 shares@ US$28.15320.8% of flowCommon StockSEC:0001628280-26-019830:0

◆

EVP, CFOExecutives5 Mar 2026PROCEPT BioRobotics Corp

0SEC

47,462 shares0Common StockSEC:0001628280-26-016151:0

◆

EVP, CFOExecutives19 Feb 2026PROCEPT BioRobotics Corp

0SEC

3,532 shares0Common StockSEC:0001628280-26-011744:0

▼

EVP, CFOExecutives18 Mar 2025PROCEPT BioRobotics Corp

41,825 USD37SEC

733 shares@ US$57.061.7% of flowCommon StockSEC:0001628280-25-013830:0

▼

EVP, CFOExecutives6 Mar 2025PROCEPT BioRobotics Corp

224,517 USD38SEC

3,662 shares@ US$61.319.1% of flowCommon StockSEC:0001628280-25-011703:0

◆

EVP, CFOExecutives3 Mar 2025PROCEPT BioRobotics Corp

0SEC

16,290 shares0Common StockSEC:0001628280-25-010602:0

◇

EVP, CFOExecutives15 Oct 2024PROCEPT BioRobotics Corp

114,000 USD19SEC

25,000 shares@ US$4.564.6% of flowCommon StockSEC:0001628280-24-043032:0

◇

EVP, CFOExecutives16 Sept 2024PROCEPT BioRobotics Corp

71,945 USD19SEC

15,917 shares@ US$4.522.8% of flowCommon StockSEC:0001628280-24-040837:0

◆

EVP, CFOExecutives6 Mar 2024PROCEPT BioRobotics Corp

0SEC

13,275 shares0Common StockSEC:0001628280-24-017005:0

▼

EVP, CFOExecutives18 Mar 2024PROCEPT BioRobotics Corp

50,002 USD37SEC

1,024 shares@ US$48.832.0% of flowCommon StockSEC:0001628280-24-012239:0

◇

EVP, CFOExecutives15 Mar 2024PROCEPT BioRobotics Corp

162,765 USD20SEC

36,010 shares@ US$4.526.6% of flowCommon StockSEC:0001628280-24-011738:0

◆

EVP, CFOExecutives6 Mar 2024PROCEPT BioRobotics Corp

0SEC

19,328 shares0Common StockSEC:0001628280-24-009764:0

◇

EVP, CFOExecutives12 Feb 2024PROCEPT BioRobotics Corp

101,017 USD19SEC

22,349 shares@ US$4.524.1% of flowCommon StockSEC:0001628280-24-004486:0

◇

EVP, CFOExecutives7 Feb 2024PROCEPT BioRobotics Corp

4,086 USD19SEC

904 shares@ US$4.520.2% of flowCommon StockSEC:0001628280-24-004120:0

◇

EVP, CFOExecutives9 Jan 2024PROCEPT BioRobotics Corp

78,241 USD19SEC

17,310 shares@ US$4.523.1% of flowCommon StockSEC:0001628280-24-001189:0

◇

EVP, CFOExecutives13 Dec 2023PROCEPT BioRobotics Corp

323,022 USD20SEC

71,465 shares@ US$4.5213.1% of flowCommon StockSEC:0001628280-23-041701:0

◇

EVP, CFOExecutives6 Dec 2023PROCEPT BioRobotics Corp

19,707 USD19SEC

4,360 shares@ US$4.520.8% of flowCommon StockSEC:0001628280-23-041166:0

▼

EVP, CFOExecutives15 Jun 2023PROCEPT BioRobotics Corp

794,912 USD22SEC

22,631 shares@ US$35.124931.8% of flowCommon StockSEC:0001628280-23-022292:0

▼

EVP, CFOExecutives16 Mar 2023PROCEPT BioRobotics Corp

22,479 USD37SEC

706 shares@ US$31.840.9% of flowCommon StockSEC:0001628280-23-008459:0

▼

EVP, CFOExecutives7 Mar 2023PROCEPT BioRobotics Corp

243,705 USD38SEC

7,136 shares@ US$34.151510.0% of flowCommon StockSEC:0001628280-23-007375:0

◆

EVP, CFOExecutives16 Feb 2023PROCEPT BioRobotics Corp

0SEC

26,315 shares0Common StockSEC:0001628280-23-004325:0

◆

EVP, CFOExecutives31 Mar 2022PROCEPT BioRobotics Corp

232,513 USD20SEC

7,914 shares@ US$29.389.1% of flowCommon StockSEC:0001628280-22-008263:0

24 of 24 declarations